Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
NCT ID: NCT01101217
Last Updated: 2010-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2009-02-28
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients
NCT02335593
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
NCT02888171
Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome
NCT07109778
Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients
NCT01147354
Effects of Mesna on Homocysteine in Kidney Failure
NCT00524199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
placebo for 6 weeks
placebo
placebo daily for 6 weeks
zinc
zinc sulfate 220 mg per day orally for 6 weeks
Zinc Supplement
in 50 patients zinc sulfate 220 mg per day orally for 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zinc Supplement
in 50 patients zinc sulfate 220 mg per day orally for 6 weeks
placebo
placebo daily for 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* older than 18 years old
* serum level of zinc less than 72.6 microgram/ l in men and less than 70 microgram/ l in female
Exclusion Criteria
* malabsorption
* history of steroid or cytotoxic consumption
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shiraz University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shiraz University of Medical Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiraz University Hemodialysis Center
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.